S&P 500   2,594.17 (-99.21%)
DOW   22,021.77 (+1.78%)
QQQ   190.00 (+2.54%)
AAPL   251.94 (+1.70%)
FB   162.15 (+3.42%)
MSFT   158.29 (+5.74%)
GOOGL   1,136.79 (+2.39%)
AMZN   1,957.01 (+3.00%)
CGC   14.44 (-1.03%)
NVDA   261.28 (+3.39%)
BABA   189.06 (+0.25%)
MU   44.65 (+2.69%)
GE   7.82 (+2.63%)
TSLA   513.01 (-0.99%)
AMD   47.88 (+2.79%)
T   29.68 (-0.54%)
F   5.01 (-3.47%)
NFLX   370.31 (+3.69%)
BAC   22.26 (+3.06%)
GILD   75.10 (+3.09%)
DIS   96.94 (+0.56%)
S&P 500   2,594.17 (-99.21%)
DOW   22,021.77 (+1.78%)
QQQ   190.00 (+2.54%)
AAPL   251.94 (+1.70%)
FB   162.15 (+3.42%)
MSFT   158.29 (+5.74%)
GOOGL   1,136.79 (+2.39%)
AMZN   1,957.01 (+3.00%)
CGC   14.44 (-1.03%)
NVDA   261.28 (+3.39%)
BABA   189.06 (+0.25%)
MU   44.65 (+2.69%)
GE   7.82 (+2.63%)
TSLA   513.01 (-0.99%)
AMD   47.88 (+2.79%)
T   29.68 (-0.54%)
F   5.01 (-3.47%)
NFLX   370.31 (+3.69%)
BAC   22.26 (+3.06%)
GILD   75.10 (+3.09%)
DIS   96.94 (+0.56%)
S&P 500   2,594.17 (-99.21%)
DOW   22,021.77 (+1.78%)
QQQ   190.00 (+2.54%)
AAPL   251.94 (+1.70%)
FB   162.15 (+3.42%)
MSFT   158.29 (+5.74%)
GOOGL   1,136.79 (+2.39%)
AMZN   1,957.01 (+3.00%)
CGC   14.44 (-1.03%)
NVDA   261.28 (+3.39%)
BABA   189.06 (+0.25%)
MU   44.65 (+2.69%)
GE   7.82 (+2.63%)
TSLA   513.01 (-0.99%)
AMD   47.88 (+2.79%)
T   29.68 (-0.54%)
F   5.01 (-3.47%)
NFLX   370.31 (+3.69%)
BAC   22.26 (+3.06%)
GILD   75.10 (+3.09%)
DIS   96.94 (+0.56%)
S&P 500   2,594.17 (-99.21%)
DOW   22,021.77 (+1.78%)
QQQ   190.00 (+2.54%)
AAPL   251.94 (+1.70%)
FB   162.15 (+3.42%)
MSFT   158.29 (+5.74%)
GOOGL   1,136.79 (+2.39%)
AMZN   1,957.01 (+3.00%)
CGC   14.44 (-1.03%)
NVDA   261.28 (+3.39%)
BABA   189.06 (+0.25%)
MU   44.65 (+2.69%)
GE   7.82 (+2.63%)
TSLA   513.01 (-0.99%)
AMD   47.88 (+2.79%)
T   29.68 (-0.54%)
F   5.01 (-3.47%)
NFLX   370.31 (+3.69%)
BAC   22.26 (+3.06%)
GILD   75.10 (+3.09%)
DIS   96.94 (+0.56%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Stemline TherapeuticsGalera TherapeuticsMinerva NeurosciencesGemphire TherapeuticsFulcrum Therapeutics
SymbolNASDAQ:STMLNASDAQ:GRTXNASDAQ:NERVNASDAQ:GEMPNASDAQ:FULC
Price Information
Current Price$5.04$9.64$6.48$14.57$12.17
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$15.13$19.75$20.25N/A$25.33
% Upside from Price Target200.10% upside104.88% upside212.50% upsideN/A108.16% upside
Trade Information
Market Cap$221.65 million$224.13 million$245.12 million$216.66 million$278.45 million
Beta1.43N/A1.452.82N/A
Average Volume954,05524,582459,751116,318142,333
Sales & Book Value
Annual Revenue$43.22 millionN/AN/AN/AN/A
Price / Sales5.87N/AN/AN/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$3.26 per share$2.81 per share$0.71 per share$0.54 per share$3.73 per share
Price / Book1.55N/AN/AN/AN/A
Profitability
Net Income$-76,820,000.00$-51,930,000.00$-72,180,000.00$-23,640,000.00$-82,680,000.00
EPS($1.83)($16.31)($1.85)N/A($8.13)
Trailing P/E RatioN/AN/AN/A0.00N/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-177.74%N/AN/AN/AN/A
Return on Equity (ROE)-56.00%N/A-126.64%-419.70%N/A
Return on Assets (ROA)-47.31%N/A-65.86%-173.05%-90.08%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.01%N/AN/AN/A
Current Ratio8.00%12.13%7.11%0.67%8.24%
Quick Ratio7.95%12.13%7.11%0.67%8.24%
Ownership Information
Institutional Ownership Percentage81.86%68.48%82.60%17.53%64.54%
Insider Ownership Percentage13.10%N/A12.00%22.70%N/A
Miscellaneous
Employees922613962
Shares Outstanding50.38 million24.82 million39.22 million14.87 million23.36 million
Next Earnings Date5/8/2020 (Estimated)6/9/2020 (Estimated)5/4/2020 (Estimated)N/A6/4/2020 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel